Article

Surgical Success: Maximizing Outcomes through Evidence-Based Medicine

The tenets of evidence-based medicine, rather than anecdotal evidence, can be used to improve cataract and refractive surgery outcomes, concluded panelists at a breakfast CME symposium on Sunday.

New Orleans-The tenets of evidence-based medicine, rather than anecdotal evidence, can be used to improve cataract and refractive surgery outcomes, concluded panelists at a breakfast CME symposium on Sunday. Moderator Michael Raizman, MD, Tufts University School of Medicine, Boston, and the faculty discussed application of evidence-based medicine to the evaluation and biocompatibility of current fluoroquinolones and maximizing the outcomes of cataract surgery and refractive surgery.

According to a statement from the American Academy of Ophthalmology, evidence-based medicine is the conscientious use of current best evidence in making decisions about the care of individual patients. The practice of evidence-based medicine integrates individual clinical expertise with the best available external clinical evidence from systematic research.

Faculty included Eduardo Alfonso, MD, University of Miami School of Medicine; Deepinder K. Dhaliwal, MD, University of Pittsburgh School of Medicine; Edward J. Holland, MD, University of Cincinnati School of Medicine; and Samuel Masket, MD, UCLA Center for Health Sciences, Los Angeles.

The meeting, held at the Hilton New Orleans Riverside, was jointly sponsored by Ophthalmology Times and the New York Eye and Ear Infirmary and supported by an unrestricted educational grant from Alcon Laboratories Inc.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
© 2025 MJH Life Sciences

All rights reserved.